ZERO WORLD RESEARCHLiterature database on amino acids & organic acids

Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review.

Cancer cell international2020Al-Koussa H, El Mais N, Maalouf H, et al.
Study designReview
SubjectUnknown

Record checks

Study design
Review
Subject
Unknown
Publication year
2020
Source
doi.org
Abstract display
Shown here
Publication status
Active
Status checked
17 Aug 2026
Collected
13 Aug 2026
Freshness
Current
Review stage
Automated
Record status
Published

Abstract

Arginine is a semi essential amino acid that is used in protein biosynthesis. It can be obtained from daily food intake or synthesized in the body through the urea cycle using l-citrulline as a substrate. Arginine has a versatile role in the body because it helps in cell division, wound healing, ammonia disposal, immune system, and hormone biosynthesis. It is noteworthy that l-arginine is the precursor for the biosynthesis of nitric oxide (NO) and polyamines. In the case of cancer cells, arginine de novo synthesis is not enough to compensate for their high nutritional needs, forcing them to rely on extracellular supply of arginine. In this review, we will go through the importance of arginine deprivation as a novel targeting therapy by discussing the different arginine deprivation agents and their mechanism of action. We will also focus on the factors that affect cell migration and on the influence of arginine on metastases through polyamine and NO.

DOI 10.1186/s12935-020-01232-9

PMID 32390765

View source →